{"nct_id":"NCT05947851","title":"A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-08-08","start_date_type":"ACTUAL","primary_completion_date":"2035-03-14","primary_completion_date_type":"ESTIMATED","completion_date":"2035-03-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}